Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016.
Ruggero LasalaFiorenzo SantoleriDavide ZanonAlessia RomagnoliPaolo AbrateAlberto CostantiniFelice MusiccoPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Most of the onco-haematological drugs approved by EMA since 2016 have neither paediatric indications nor mentions about paediatric use in SmPC. PIPs represent an opportunity, but demand for the paediatric population is still huge.